ATXI

Avenue Therapeutics, Inc. Common Stock

Delisted

ATXI was delisted on the 18th of March, 2025.

13 hedge funds and large institutions have $520K invested in Avenue Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$306K
2 +$61.9K
3 +$55K
4
VF
Virtu Financial
New York
+$38K
5
Citigroup
Citigroup
New York
+$19.5K

Top Sellers

1 -$362K
2 -$145K
3 -$143K
4
TRCT
Tower Research Capital (TRC)
New York
-$14K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$306K
2
$61.9K
3
$55K
4
$38K
5
$20.1K
6
$13K
7
$12.8K
8
$5.29K
9
$3.87K
10
$2.25K
11
$1.45K
12
$618
13
$14
14
15
16
17